Bupropion and dextromethorphan for reduction of suicide risk in depression patients | Patent Application Number 18323714
18323714
Not Appealed
Patent NumberUS 11896563 B2
Publication NumberUS 20230293456 A1
Filled DateMay 25, 2023
Priority DateDec 1, 2020
Inventor/ApplicantsHerriot Tabuteau
ExaminesWEDDINGTON, KEVIN E
Art Unit1629
Technology Center1600
Law Firm
You must be logged in to view
LoginAttorneys
Subscription-Only
View Concierge ProgramSee the invalidated claims, subscribe to our Concierge Program.
View Concierge ProgramEmpower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.